Natural course of thyroid disease profile in a population in nutrition transition: Tehran thyroid study

Archives of Iranian Medicine

Volumn 16, Issue 7, 2013, Pages 418-423

  Azizi, Fereidoun ^a   Amouzegar, Atieh ^a   Delshad, Hossein ^a   Tohidi, Maryam ^b   Mehran, Ladan ^a   Mehrabi, Yadollah ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Hyperthyroidism; Hypothyroidism; Iran; Tehran Lipid and Glucose study; Tehran thyroid study; Thyroid

Indexed keywords

ANTIHYPERTENSIVE AGENT; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IODINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CHOLESTEROL BLOOD LEVEL; CLINICAL EXAMINATION; COMMUNITY ASSESSMENT; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE COURSE; EATING HABIT; FOLLOW UP; GLUCOSE METABOLISM; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IMMOBILIZATION; INCIDENCE; IRAN; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MEDICAL HISTORY; NUTRITION TRANSITION; NUTRITIONAL ASSESSMENT; NUTRITIONAL PARAMETERS; OBESITY; POPULATION RESEARCH; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SMOKING; SYSTOLIC BLOOD PRESSURE; THYROID DISEASE; TRIACYLGLYCEROL BLOOD LEVEL; URBAN AREA;

ADULT; CARDIOVASCULAR DISEASES; DIET; HUMANS; IODINE; IRAN; LIFE STYLE; LIPIDS; MIDDLE AGED; RISK FACTORS; SODIUM CHLORIDE, DIETARY; THYROID DISEASES; YOUNG ADULT;

EID: 84879395313     PISSN: 10292977     EISSN: 17353947     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Canaris GJ, Manowitz NR, Mayor, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med. 2004; 160: 526-534.
2. Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, DM et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf). 1995; 43: 55-68.
3. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, SpencerCA, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002; 87: 489-499.
4. Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf). 1977; 7: 481-493.
5. Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. EndocrRev. 2008; 29: 76-131.
6. Rosario PW. Natural history of subclinical hyperthyroidism in elderly patients with TSH between 0.1 and 0.4 mlU/L: a prospective study. Clin Endocrinol (Oxf). 2010; 72: 685-688.
7. Das G, Ojewuyi TA, Baglioni P, Geen J, Premawardhana LD, Okosieme OE. Serum thyrotrophin at baseline predicts the natural course of subclinical hyperthyroidism. Clin Endocrinol (Oxf). 2012; 77: 146-151.
8. Laurberg P, Pedersen KM, Vestergaard H, Sigurdsson VG. High inci dence of multinodular toxic goitre in the elderly population in a low iodine intake area vs. high incidence of Graves' disease in the young in a high iodine intake area: comparative surveys of thyrotoxicosis epidemiology in East-Jutland Denmark and Iceland. J Intern Med. 1991; 229: 415-420.
9. Sawin CT, Castelli WP, Hershman JM, McNamara P, Bacharach P. The aging thyroid. Thyroid deficiency in the Framingham Study. Arch Intern Med. 1985; 145: 1386-1388.
10. Hetzel BS PC, editors, SOSfor a Billion: The Conquest of Iodine Deficiency Disorders. New Dehli: Oxford University Press (ICCIDD) 1996; 2.
11. Yang L, Jiang D, Qi W, Zhang T, Feng Y, Gao L, et al. Subclinical hyperthyroidism and the risk of cardiovascular events and all-cause mortality: an updated meta-analysis of cohort studies. Eur J Endocrinol. 2012; 167: 75-84.
12. Bell RJ, Rivera-Woll L, Davison SL, Topliss DJ, Donath S, DavisSR. Well-being, health-related quality of life and cardiovascular disease risk profile in women with subclinical thyroid disease-a community-based study. Clin Endocrinol (Oxf). 2007; 66: 548-556.
13. Mehio Sibai A, Nasreddine L, Mokdad AH, Adra N, Tabet M, HwallaN. Nutrition transition and cardiovascular disease risk factors in Middle East and North Africa countries: reviewing the evidence. Ann Nutr Metab. 2010; 57: 193-203.
14. Azizi F, Ghanbarian A, Momenan AA, Hadaegh F, Mirmiran P, Hedaya-ti M, Mehrabi Y, Zahedi-Asl S; Tehran Lipid and Glucose Study Group. Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials. 2009; 10: 5.
15. Delshad H, Amouzegar A, Mirmiran P, Mehran L, AziziF. Eighteen years of continuously sustained elimination of iodine deficiency in the Islamic Republic of Iran: the vitality of periodic monitoring. Thyroid. 2012; 22: 415-421.
16. Azizi F, Rahmani M, Emami H, Madjid M. Tehran Lipid and Glucose Study: Rationale and Design. CVD Prevention. 2004; 3: 242-247.
17. Clearfield MB. The national cholesterol education program adult treatment panel ill guidelines. J Am Osteopath Assoc. 2003; 103(Suppl 1): 1-5.
18. The Joint National Committee on prevention, evaluation, and treatment of high blood pressure. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med. 1997; 157: 2413-2446.
19. World Health Organization. Diabetes mellitus. Report of a WHO Study Group. World Health Organ Tech Rep Ser. 1985; 727: 1-113.
20. WHO, UNICEF, ICCIDD, editors, Assessment of the iodine deficiency disorders and monitoring their elimination: A guide for programme managers. 2001; 2: Geneva: WHO.
21. Prineas RJ, Crow RSB H. The Minnesota code manual of electrocar-diographicfindings: standards and procedures for measurements and classification. 1982; Boston: John Wright PCG.
22. Prineas RJ, Castle CH, Curb JD, Harrist R, Lewin A, Stamler J. Hypertension detection and follow-up program. Baseline electrocardiographic characteristics of the hypertensive participants. Hypertension. 1983; 5: 160-189.
23. Rose G, McCartney P, Reid DD. Self-administration of a questionnaire on chest pain and intermittent claudication. Br J Prev Soc Med. 1977; 31: 42-48.
24. Ainsworth BE, Jacobs DR, Leon AS. Validity and reliability of selfreported physical activity status: the Lipid Research Clinics questionnaire. Med Sci Sports Exerc. 1993; 25: 92-98.
25. Kriska AM, Knowler WC, LaPorte RE, Drash AL, Wing RR, Blair SN, et al. Development of questionnaire to examine relationship of physical activity and diabetes in Pima Indians. Diabetes Care. 1990; 13: 401-411.
26. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18: 499-502.
27. Ghaffarpour M, Houshiar-Rad A, Kianfar H, editors. The manual for household measures, cooking yields factors and edible portion of food. Tehran: Keshaverzi press; 1999.
28. Regional meetingfor the promotion of iodized salt in the EasternMedi-terranean, Middle East, and North Africa Region. 10-12 April 2004, Dubai, United Arab Emirates.
29. Delshad H, Mehran L, Tohidi M, Assadi M, Azizi F. The incidence of thyroid function abnormalities and natural course of subclinical thyroid disorders, Tehran, I. R. Iran. J Endocrinol Invest. 2012; 35:516-521.
30. Asvold BO, Vatten LJ, Nilsen TI, BjoroT. The association between TSH within the reference range and serum lipid concentrations in a population-based study. The HUNT Study. Eur J Endocrinol. 2007; 156: 181-186.
31. Tagami T, Tamanaha T, Shimazu S, Honda K, Nanba K, Nomura H, et al. Lipid profiles in the untreated patients with Hashimoto thyroiditis and the effects of thyroxine treatment on subclinical hypothyroidism with Hashimoto thyroiditis. Endocr. 2010; 57: 253-258.
32. Teixeira Pde F, Reuters VS, Ferreira MM, Almeida CP, Reis FA, Buescu A, et al. Lipid profile in different degrees of hypothyroidism and effects of levothyroxine replacement in mild thyroid failure. Transl Res. 2008; 151: 224-231.
33. Darnton-Hill I, Nishida C, JamesWP A life course approach to diet, nutrition and the prevention of chronic diseases. Public Health Nutr. 2004; 7: 101-121.
34. Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, et al. Lipid profiles and cardiovascular disease in the Whickham area with particular reference to thyroid failure. Clin Endocrinol (Oxf). 1977; 7: 495-508.
35. Hueston WJ, PearsonWS. Subclinical hypothyroidism and the risk of hypercholesterolemia. Ann FamMed. 2004; 2: 351-355.
36. Biondi B, Palmieri EA, Fazio S, Cosco C, Nocera M, Sacca L, et al. Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients. J Clin En-docrinolMetab. 2004; 85: 4701-4705.
37. Napoli R, Biondi B, Guardasole V, Matarazzo M, Pardo F, Angelini V, et al. Impact of hyperthyroidism and its correction on vascular reactivity in humans. Circulation. 2001; 104: 3076-3080.
38. Biondi B, Klein I. Hypothyroidism as a risk factor for cardiovascular disease. Endocrine. 2004; 24: 1-13.
39. Rodondi N, den Elzen WP, Bauer DC, Cappola AR, Razvi S, Walsh JP, et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA. 2010; 304: 1365-1374.
40. Collet TH, Gussekloo J, Bauer DC, den Elzen WP, Cappola AR, Balmer P, et al. Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Arch Intern Med. 2012; 172: 799-809.
41. Ochs N, Auer R, Bauer DC, Nanchen D, Gussekloo J, Cornuz J, et al. Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Ann Intern Med. 2008; 148: 832-845.